Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

NewsGuard 100/100 Score

XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it has begun distributing and selling Cobroxin through mass food and drug retail chains in the Northeast, Southeast, Middle Atlantic and Midwest regions. The Company has also announced that sales of Cobroxin have exceeded projections for the first 45 days of 2010.

“Reorder rates from our customers have been very strong at all levels of our distribution grid and have required us to reorder inventory four times from Nutra Pharma since placing our initial order for the product”

“Sales of Cobroxin have already exceeded our projections for the beginning of this year,” explained Frank Rizzo, President and CEO of XenaCare Holdings. “Reorder rates from our customers have been very strong at all levels of our distribution grid and have required us to reorder inventory four times from Nutra Pharma since placing our initial order for the product,” he added.

To support sales of Cobroxin, XenaCare has committed to a $4 million print advertising campaign for the first 12-months. This campaign includes advertisements in Health, Prevention, Self, Soap Opera Digest, Working Mother, Woman’s Day, Shape, Martha Stewart, Redbook, Ladies Home Journal, Allure, Wired, Web M.D. and Arthritis Today magazines.

In addition to its national print campaign, the Company has contracted with the Home Shopping Group to organize direct response television commercials set to begin airing in March 2010. Additionally, the Company has committed to a $3 million television broadcast campaign.

Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Additional benefits to Cobroxin include:

  • All Natural
  • Non-Addictive
  • Non-Narcotic
  • Non-Opiate
  • Long Lasting

XenaCare Holdings was granted a license by Nutra Pharma Corporation (OTCBB:NPHC) to market and distribute Cobroxin within the United States.

Source:

XenaCare Holdings, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings